Ubs Asset Management Americas Inc Ionis Pharmaceuticals Inc Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 659,435 shares of IONS stock, worth $22.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

659,435

Previous 619,641 6.42%

Holding current value

$22.1 Million

Previous $21.7 Million 8.16%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	BUY	$30.17 - $34.97 $1.2 Million - $1.39 Million	39,794 Added 6.42%	659,435 $19.9 Million
Q4 2024 Feb 14, 2025	BUY	$33.73 - $40.36 $11.3 Million - $13.5 Million	333,944 Added 116.89%	619,641 $21.7 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.39 Million - $1.79 Million	-34,593 Reduced 10.8%	285,697 $11.4 Million
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $4.88 Million - $6.39 Million	133,963 Added 71.9%	320,290 $15.3 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $399,752 - $475,667	9,213 Added 5.2%	186,327 $9.43 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $14,668 - $17,956	381 Added 0.22%	177,114 $8.03 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $31,464 - $38,604	937 Added 0.53%	176,733 $6.32 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $3.85 Million - $4.83 Million	-103,828 Reduced 37.13%	175,796 $6.64 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $2.7 Million - $3.59 Million	73,835 Added 35.88%	279,624 $12.4 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $35,420 - $48,031	-1,117 Reduced 0.54%	205,789 $7.62 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $691,841 - $857,624	23,154 Added 12.6%	206,906 $7.66 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $79,058 - $108,353	3,087 Added 1.71%	183,752 $5.59 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $145,026 - $175,338	4,324 Added 2.45%	180,665 $6.06 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $7.88 Million - $10.8 Million	-228,183 Reduced 56.41%	176,341 $7.03 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $211,997 - $318,070	-4,987 Reduced 1.22%	404,524 $18.2 Million
Q4 2020 Mar 01, 2021	BUY	$45.3 - $60.27 $2.75 Million - $3.65 Million	60,612 Added 17.37%	409,511 $23.2 Million
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $486,789 - $645,804	10,259 Added 3.03%	348,899 $16.6 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $1.04 Million - $1.35 Million	-22,092 Reduced 6.12%	338,640 $20 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $298,937 - $455,592	7,186 Added 2.03%	360,732 $17.1 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $878,401 - $1.06 Million	16,312 Added 4.84%	353,546 $21.4 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $71,285 - $87,085	1,207 Added 0.36%	337,234 $20.2 Million
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $12.9 Million - $17.9 Million	207,590 Added 161.63%	336,027 $0
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $836,929 - $1.28 Million	15,815 Added 14.04%	128,437 $0
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $219,712 - $301,629	5,066 Added 4.71%	112,622 $6.09 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $54,200 - $67,876	1,264 Added 1.19%	107,556 $0
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $7.08 Million - $8.86 Million	-174,781 Reduced 62.18%	106,292 $0
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $239,971 - $299,692	-5,444 Reduced 1.9%	281,073 $0
Q4 2017 Feb 09, 2018	BUY	$50.3 - $64.39 $821,046 - $1.05 Million	16,323 Added 6.04%	286,517 $0
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $12.3 Million - $16.1 Million	270,194	270,194 $0

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Ionis Pharmaceuticals Inc Transaction History